Anti-IgE Therapy
Overview
Authors
Affiliations
IgE has a central role in the initiation of allergic hypersensitivity reactions. Pioneered by the development of humanized monoclonal antibodies directed against IgE, anti-IgE therapy represents an original approach to the treatment of allergic disease and has demonstrated promise in preventing the symptoms of asthma, allergic rhinitis, and food allergy. The primary mechanism of action of anti-IgE therapy is the reduction in serum levels of IgE and FcepsilonRI expression on mast cells and basophils.
Case Report: Mastocytosis: The Long Road to Diagnosis.
Rama T, Martins D, Gomes N, Pinheiro J, Nogueira A, Delgado L Front Immunol. 2021; 12:635909.
PMID: 33643319 PMC: 7907169. DOI: 10.3389/fimmu.2021.635909.
Biological therapies for atopic dermatitis: An update.
Deleanu D, Nedelea I Exp Ther Med. 2019; 17(2):1061-1067.
PMID: 30679974 PMC: 6327672. DOI: 10.3892/etm.2018.6989.
Anti-immunoglobulin e therapy.
Segal M, Stokes J, Casale T World Allergy Organ J. 2013; 1(10):174-83.
PMID: 23282676 PMC: 3651047. DOI: 10.1097/WOX.0b013e318187a310.
Use of omalizumab in the treatment of food allergy and anaphylaxis.
Lieberman J, Chehade M Curr Allergy Asthma Rep. 2012; 13(1):78-84.
PMID: 23065311 DOI: 10.1007/s11882-012-0316-x.
Biologic modulators in allergic and autoinflammatory diseases.
Broderick L, Tourangeau L, Kavanaugh A, Wasserman S Curr Opin Allergy Clin Immunol. 2011; 11(4):355-60.
PMID: 21659854 PMC: 3154953. DOI: 10.1097/ACI.0b013e328348a882.